Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
F5, INC. | Director | Common Stock | 12K | $2.43M | $202.00 | Sep 5, 2024 | Direct |
Denali Therapeutics Inc. | Director | Common Stock | 21.5K | $438K | $20.39 | May 31, 2024 | Direct |
F5, INC. | Director | Restricted Stock Unit | 1.31K | $249K | $190.43 | Mar 14, 2024 | Direct |
Sarcos Technology & Robotics Corp | Director | Common Stock | 265K | $157K | $0.59 | Jun 14, 2023 | Direct |
Accolade, Inc. | Director | Common Stock | 28.3K | $105K | $3.71 | Aug 6, 2024 | Direct |
Accolade, Inc. | Director | Restricted Stock Units | 0 | $0 | $3.71 | Aug 6, 2024 | Direct |
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17.9K | May 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FFIV | F5, INC. | Sep 5, 2024 | 1 | $0 | 4 | Sep 6, 2024 | Director |
ACCD | Accolade, Inc. | Aug 6, 2024 | 2 | $0 | 4 | Aug 8, 2024 | Director |
ACCD | Accolade, Inc. | Aug 6, 2024 | 1 | $0 | 4 | Aug 8, 2024 | Director |
DNLI | Denali Therapeutics Inc. | May 31, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
FFIV | F5, INC. | Mar 13, 2024 | 3 | $0 | 4 | Mar 15, 2024 | Director |
FFIV | F5, INC. | Sep 5, 2023 | 1 | $0 | 4 | Sep 7, 2023 | Director |
ACCD | Accolade, Inc. | Aug 18, 2023 | 1 | $0 | 4 | Aug 22, 2023 | Director |
ACCD | Accolade, Inc. | Jul 25, 2023 | 2 | $0 | 4 | Jul 27, 2023 | Director |
STRC | Sarcos Technology & Robotics Corp | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
DNLI | Denali Therapeutics Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
FFIV | F5, INC. | Mar 8, 2023 | 3 | $0 | 4 | Mar 10, 2023 | Director |
ACCD | Accolade, Inc. | Feb 28, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Director |
ACCD | Accolade, Inc. | Dec 2, 2022 | 2 | $0 | 4 | Dec 2, 2022 | Director |
ACCD | Accolade, Inc. | Aug 31, 2022 | 2 | $0 | 4 | Sep 1, 2022 | Director |
ACCD | Accolade, Inc. | Jul 26, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Director |
ACCD | Accolade, Inc. | Jul 21, 2022 | 2 | $25.7K | 4 | Jul 25, 2022 | Director |
STRC | Sarcos Technology & Robotics Corp | Jun 29, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
DNLI | Denali Therapeutics Inc. | Jun 2, 2022 | 2 | $0 | 4 | Jun 6, 2022 | Director |
ACCD | Accolade, Inc. | May 31, 2022 | 2 | $0 | 4 | Jun 2, 2022 | Director |
FFIV | F5, INC. | Mar 9, 2022 | 3 | $0 | 4 | Mar 11, 2022 | Director |
ACCD | Accolade, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
STRC | Sarcos Technology & Robotics Corp | Dec 9, 2021 | 1 | $0 | 4 | Dec 29, 2021 | Director |
STRC | Sarcos Technology & Robotics Corp | Sep 24, 2021 | 0 | $0 | 3 | Sep 24, 2021 | Director |
ACCD | Accolade, Inc. | Jul 22, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |
DNLI | Denali Therapeutics Inc. | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
DNLI | Denali Therapeutics Inc. | Jun 1, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
FFIV | F5 NETWORKS, INC. | May 11, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |